Literature DB >> 21110405

Psychometric properties of the panic disorder severity scale: clinician-administered and self-report versions.

Lisa A Wuyek1, Martin M Antony, Randi E McCabe.   

Abstract

The Panic Disorder Severity Scale (PDSS) is a seven-item scale designed to assess overall severity of panic disorder symptoms. Although the PDSS is widely used, there have been limited independent studies confirming reliability and validity, particularly of the self-report version of the PDSS, and even fewer studies directly comparing the two versions. Given the need for psychometrically sound measures that comprehensively assess the main features of panic disorder, this study examined the psychometric properties of both the clinician-administered and self-report versions of the PDSS. As the PDSS targets symptom severity across a number of specific domains, PDSS items were compared to several scales designed to measure similar constructs, including the Anxiety Sensitivity Index, Illness Intrusiveness Ratings Scale, Mobility Inventory for Agoraphobia and Agoraphobic Cognitions Questionnaire. Results indicated acceptable reliability for both the clinician-administered and self-report versions. Results indicated acceptable validity for the clinician-administered PDSS and promising validity for the self-report. However, correlations between both versions of the PDSS and comparison measures were lower than predicted. Results also indicated that scores on the self-report and clinician-administered versions were significantly associated, although correlations between specific PDSS items on the two versions were also lower than expected. Results suggest that total scores on each of the PDSS versions provide a useful indication of panic-related severity. However, clinicians and researchers are cautioned against relying on scores from individual items to measure specific constructs due to their poor specificity.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 21110405     DOI: 10.1002/cpp.703

Source DB:  PubMed          Journal:  Clin Psychol Psychother        ISSN: 1063-3995


  10 in total

1.  Defensive mobilization in specific phobia: fear specificity, negative affectivity, and diagnostic prominence.

Authors:  Lisa M McTeague; Peter J Lang; Bethany C Wangelin; Marie-Claude Laplante; Margaret M Bradley
Journal:  Biol Psychiatry       Date:  2012-03-03       Impact factor: 13.382

2.  Aversive imagery in panic disorder: agoraphobia severity, comorbidity, and defensive physiology.

Authors:  Lisa M McTeague; Peter J Lang; Marie-Claude Laplante; Margaret M Bradley
Journal:  Biol Psychiatry       Date:  2011-05-08       Impact factor: 13.382

3.  French adaptation and validation of the Panic Disorder Severity Scale-self-report.

Authors:  Pasquale Roberge; Patricia Marx; Jonathan Couture; Nathalie Carrier; Annie Benoît; Martin D Provencher; Martin M Antony; Peter J Norton
Journal:  BMC Psychiatry       Date:  2022-06-27       Impact factor: 4.144

4.  A psychometric evaluation of the panic disorder severity scale for children and adolescents.

Authors:  R Meredith Elkins; Donna B Pincus; Jonathan S Comer
Journal:  Psychol Assess       Date:  2013-12-02

5.  Efficacy of the Unified Protocol for transdiagnostic treatment of comorbid psychopathology accompanying emotional disorders compared to treatments targeting single disorders.

Authors:  Stephanie Jarvi Steele; Todd J Farchione; Clair Cassiello-Robbins; Amantia Ametaj; Sophia Sbi; Shannon Sauer-Zavala; David H Barlow
Journal:  J Psychiatr Res       Date:  2018-08-03       Impact factor: 4.791

6.  Digital IAPT: the effectiveness & cost-effectiveness of internet-delivered interventions for depression and anxiety disorders in the Improving Access to Psychological Therapies programme: study protocol for a randomised control trial.

Authors:  Derek Richards; Daniel Duffy; Brid Blackburn; Caroline Earley; Angel Enrique; Jorge Palacios; Matthew Franklin; Gabriella Clarke; Sarah Sollesse; Sarah Connell; Ladislav Timulak
Journal:  BMC Psychiatry       Date:  2018-03-02       Impact factor: 3.630

7.  Study Protocol for a Randomized Double Blind, Placebo Controlled Trial Exploring the Effectiveness of a Micronutrient Formula in Improving Symptoms of Anxiety and Depression.

Authors:  Meredith Blampied; Caroline Bell; Claire Gilbert; Joseph Boden; Rebecca Nicholls; Julia J Rucklidge
Journal:  Medicines (Basel)       Date:  2018-06-14

8.  Anxiety Sensitivity Moderates the Impact of COVID-19 Perceived Stress on Anxiety and Functional Impairment.

Authors:  Kara Manning; Natasha D Eades; Brooke Y Kauffman; Laura J Long; Angela L Richardson; Lorra Garey; Michael J Zvolensky; Matthew W Gallagher
Journal:  Cognit Ther Res       Date:  2021-01-21

9.  Single-item screening for agoraphobic symptoms: validation of a web-based audiovisual screening instrument.

Authors:  Wouter van Ballegooijen; Heleen Riper; Tara Donker; Katherina Martin Abello; Isaac Marks; Pim Cuijpers
Journal:  PLoS One       Date:  2012-07-23       Impact factor: 3.240

10.  An Internet-based guided self-help intervention for panic symptoms: randomized controlled trial.

Authors:  Wouter van Ballegooijen; Heleen Riper; Britt Klein; David Daniel Ebert; Jeannet Kramer; Peter Meulenbeek; Pim Cuijpers
Journal:  J Med Internet Res       Date:  2013-07-29       Impact factor: 5.428

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.